Evidence map›Paper›PMID 25405959›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2014

Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems.

Kathryn E Arnold, A Ross Brown, Gerald T Ankley, John P Sumpter

Abstract read
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Removal of pharmaceutical pollutants by adsorption onto novel metal-organic frameworks.Environmental science and pollution research international · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Toxicological effect of acetaminophen, metamizole, and nimesulide cocktail on early development of zebrafish.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2024
    Article
  15. Article
  16. Functional analysis, diversity, and distribution of theApplied and environmental microbiology · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kathryn E ArnoldEnvironment Department, University of York, York, UK kathryn.arnold@york.ac.uk.ORCID http://orcid.org/0000-0002-6485-6065
A Ross BrownAstraZeneca Safety, Health and Environment, Brixham Environmental Laboratory, Brixham, UK University of Exeter, Biosciences, College of Life and Environmental Sciences, Exeter, UK.ORCID http://orcid.org/0000-0002-3892-8993
Gerald T AnkleyUS Environmental Protection Agency, Duluth, MN 55804, USA.
John P SumpterInstitute for the Environment, Brunel University, Uxbridge, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global pharmaceutical consumption is rising with the growing and ageing human population and more intensive food production. Recent studies have revealed pharmaceutical residues in a wide range of ecosystems and organisms. Environmental concentrations are often low, but pharmaceuticals typically are designed to have biological effects at low doses, acting on physiological systems that can be evolutionarily conserved across taxa. This Theme Issue introduces the latest research investigating the risks of environmentally relevant concentrations of pharmaceuticals to vertebrate wildlife. We take a holistic, global view of environmental exposure to pharmaceuticals encompassing terrestrial, freshwater and marine ecosystems in high- and low-income countries. Based on both field and laboratory data, the evidence for and relevance of changes to physiology and behaviour, in addition to mortality and reproductive effects, are examined in terms of the population- and community-level consequences of pharmaceutical exposure on wildlife. Studies on uptake, trophic transfer and indirect effects of pharmaceuticals acting via food webs are presented. Given the logistical and ethical complexities of research in this area, several papers focus on techniques for prioritizing which compounds are most likely to harm wildlife and how modelling approaches can make predictions about the bioavailability, metabolism and toxicity of pharmaceuticals in non-target species. This Theme Issue aims to help clarify the uncertainties, highlight opportunities and inform ongoing scientific and policy debates on the impacts of pharmaceuticals in the environment.

Indexed as

Animals, WildEcosystemAnimalsConservation of Natural ResourcesEcotoxicologyEnvironmental ExposureEnvironmental PollutantsHumansPharmaceutical PreparationsVertebratesEnvironmental PollutantsPharmaceutical Preparationscontaminantsecotoxicologyenvironmental risk assessmentpharmaceuticalspopulation ecologysewage

Identifiers

PMID25405959
PMCPMC4213582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.